ArticleFrontiers in oncology2025

RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant chemotherapy.

Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.